UK Blood Transfusion Diagnostics Market Size & Outlook
UK blood transfusion diagnostics market, 2016-2027 (US$M)
Related Markets
UK blood transfusion diagnostics market highlights
- The UK blood transfusion diagnostics market generated a revenue of USD 221.6 million in 2020 and is expected to reach USD 366.3 million by 2027.
- The UK market is expected to grow at a CAGR of 7.4% from 2021 to 2027.
- In terms of segment, reagents & kits was the largest revenue generating product in 2020.
- Reagents & Kits is the most lucrative product segment registering the fastest growth during the forecast period.
Blood transfusion diagnostics market data book summary
| Market revenue in 2020 | USD 221.6 million |
| Market revenue in 2027 | USD 366.3 million |
| Growth rate | 7.4% (CAGR from 2020 to 2027) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & Kits |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents & Kits, Instruments |
| Key market players worldwide | Grifols SA Ordinary Shares - Class A, Bio-Rad Laboratories Inc, Roche Holding AG ADR, Quotient Sciences, Abbott Laboratories, BioMerieux SA, Siemens Healthineers AG ADR, MedGenome, Beckman Coulter |
Other key industry trends
- In terms of revenue, UK accounted for 6.0% of the global blood transfusion diagnostics market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
- In Europe, Germany blood transfusion diagnostics market is projected to lead the regional market in terms of revenue in 2027.
- UK is the fastest growing regional market in Europe and is projected to reach USD 366.3 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood Transfusion Diagnostics Market Scope
Blood Transfusion Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK blood transfusion diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood transfusion diagnostics market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 66.11% in 2020. Horizon Databook has segmented the UK blood transfusion diagnostics market based on reagents & kits, instruments covering the revenue growth of each sub-segment from 2016 to 2027.
The UK is expected to grow at the fastest growth rate over the forecast period owing to new donations registered in the country, rising prevalence of chronic diseases, and well-established healthcare infrastructure.
According to NHS data, around 416,381 new blood donation registrations were recorded during the period 2019-2021 in the UK, whilst the number of new donations accounted for 131,825 in the same year. Out of the 65 million population, approximately 1.7 million people donate blood.
This is expected to save the lives of 15,000 people living with sickle cell disease in the country as well as 300 newborn babies, who are born with this disease. Thus, rise in blood donation awareness and increase in the number of people donating blood are some of the factors driving regional market growth.
Reasons to subscribe to UK blood transfusion diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK blood transfusion diagnostics market databook
-
Our clientele includes a mix of blood transfusion diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK blood transfusion diagnostics market, including forecasts for subscribers. This country databook contains high-level insights into UK blood transfusion diagnostics market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
UK blood transfusion diagnostics market size, by product, 2016-2027 (US$M)
UK Blood Transfusion Diagnostics Market Share, 2020 & 2027 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
